Champlain Investment Partners’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$43.5M Sell
318,955
-374,900
-54% -$46.1M 1.12% 21
2026
Q1
$81.7M Sell
693,855
-310,096
-31% -$43.3M 1.04% 42
2025
Q4
$165M Sell
1,003,951
-335,295
-25% -$52.5M 1.67% 6
2025
Q3
$179M Sell
1,339,246
-61,842
-4% -$7.51M 1.35% 15
2025
Q2
$174M Sell
1,401,088
-62,907
-4% -$8.01M 1.22% 18
2025
Q1
$186M Sell
1,463,995
-79,535
-5% -$12.2M 1.35% 16
2024
Q4
$222M Buy
1,543,530
+122,595
+9% +$17.6M 1.41% 18
2024
Q3
$211M Buy
1,420,935
+850,345
+149% +$122M 1.28% 27
2024
Q2
$71.9M Sell
570,590
-4,405
-0.8% -$690K 0.44% 90
2024
Q1
$106M Sell
574,995
-351,445
-38% -$66.9M 0.61% 68
2023
Q4
$167M Buy
926,440
+71,250
+8% +$11.1M 0.99% 36
2023
Q3
$136M Buy
855,190
+244,445
+40% +$40M 0.88% 47
2023
Q2
$86.4M Buy
610,745
+54,715
+10% +$8.77M 0.53% 81
2023
Q1
$93.6M Buy
556,030
+208,630
+60% +$37.2M 0.59% 75
2022
Q4
$58.8M Buy
347,400
+128,665
+59% +$23.3M 0.38% 99
2022
Q3
$40.9M Buy
+218,735
New +$46.1M 0.28% 112

Other funds holding RGEN

Champlain Investment Partners's RGEN Position: Q2 2026 in Review

Champlain Investment Partners reduced its Repligen (RGEN) stake by 54% in Q2 2026, selling an estimated $46.1M and leaving 318,955 shares worth $43.5M. The position accounts for 1.12% of the portfolio, ranked #21.

Champlain Investment Partners first reported a position in RGEN in Q3 2022 and has held it in 16 quarters since. The position peaked at $222M in Q4 2024. 481 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Champlain Investment Partners held 318,955 shares of Repligen worth $43.5M as of Q2 2026.
  • Champlain Investment Partners sold 374,900 Repligen shares in Q2 2026, an estimated $46.1M.
  • Repligen made up 1.12% of Champlain Investment Partners's portfolio in Q2 2026, its #21 holding.
  • Champlain Investment Partners first reported a position in Repligen in Q3 2022 and has held it in 16 quarters since.
  • Champlain Investment Partners's Repligen position peaked at $222M in Q4 2024.
  • 481 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Champlain Investment Partners's 13F filing for Q2 2026, filed 12 Aug 2026.